A 61-year-old man with bilateral purpura of the lower limbs and subsequent edema, was hospitalization after renal dysfunction developed. The presence of hepatitis C virus (HCV) RNA and cryoglobulin and the finding of membranoproliferative glomerulonephritis on renal biopsy led to a diagnosis of HCV-related glomerulonephritis due to cryoglobulinemia. Because of the pre-existence of nephrotic syndrome and the continuously increasing serum level of creatinine, treatment with cryofiltration, interferon, and steroids was started. After 5 cryofiltration sessions, the cryocrit level had decreased to 1% and the levels of serum creatinine and proteinuria had also decreased. However, 3 weeks after the start of treatment, nephrotic syndrome developed again and was accompanied by lower-extremity mononeuropathy and renal dysfunction. Thereafter, the patient showed disorientation, an affective disorder, and delirium, and his condition gradually deteriorated. Radiological examination of the head and examination of the cerebrospinal fluid showed no abnormalities. Despite the withdrawal of the interferon therapy and the reduction of the steroid dose, the patient's conditions remained unchanged, and the level of consciousness deteriorated. Although cryofiltration had beneficial effects and plasma exchange was continuously performed, the patient died on the 74th hospital day. Because of the significant changes due to ventilatory support and hemorrhage associated with disseminated intravascular coagulation, the autopsy findings did not allow us to definitively determine whether the symptoms had been caused by the HCV-related membranoproliferative glomerulonephritis or the interferon therapy or both. We have reported this case to provide insight into whether interferon therapy should be administered for HCVrelated membranoproliferative glomerulonephritis with marked neurological symptoms due to cryoglobulinemia. (J Nippon Med Sch 2015; 82: 193 201) 
Introduction
Hepatitis C virus (HCV) infection leads to chronic liver disease but also to extrahepatic manifestations, including kidney disease 1 3 . Membranoproliferative glomerulonephritis (MPGN) is the typical type of HCV-related glomerulonephritis 4 6 . Chronic infection with HCV can lead to the immune complex syndromes of cryoglobulinemia and membranoproliferative glomerulonephritis 7, 8 .
The pathogenetic mechanisms for these conditions remain unclear.
Treatment of HCV-related cryoglobulinemia and MPGN is difficult. Antiviral therapy is effective in clearing HCV infection in some patients, but these conditions can be severe and resistant to antiviral therapy 9, 10 . Some There is increased lobulation, hypercellularity in the mesangium, and thickening of the capillary wall (×400). Cryofiltration was started on day 18, because the patient showed elevated serum creatinine levels and progressive kidney dysfunction. Also, treatment was also started with IFNα2-a (300 mU×3! week) and corticosteroids (prednisolone, 50 mg! day). The system circuit for cryoglobulin filtration was that for standard doublefiltration plasmapheresis with an added thermoregulator.
For plasma separation, a Plasmaflo OP-08W plasma separator (Asahi Kasei Medical Co., Ltd., Tokyo) was used.
Then, the plasma was chilled to 4 , and aggregated cryoglobulins were removed with a Cascadeflo EC50W plasma component separator (Asahi Kasei Medical) (Fig.   4 ). This procedure was performed a total of 5 times, and
the cryocrit values decreased to as low as 1%, and the serum creatinine level decreased. However, the urinary protein level did not decrease significantly. The HCV RNA was not detected with the polymerase chain reac- 
Histological Findings
The systemic findings were acute renal failure due to HCV-related nephropathy in association with hemorrhagic diathesis. Neurological findings were: 1) respirator brain, with marked edema; 2) multiple fresh hemorrhages with septicemia, associated with disseminated intravascular coagulation and its sequelae; and 3) mild senile changes limited to the hippocampus through the entorhinal cortex, with senile plaques.
Discussion
In the present case, the history of blood transfusion was not available, but the purpura, edema, and elevation of urinary protein during 8 years of HCV infection fulfill the criteria for HCV-induced glomerulonephritis. Furthermore, despite fluorescent HCV-core antibody techniques and enzyme immunoassay, we were not able to identify HCV in the kidney tissues. However, the clinical course was consistent with previous reports that cryoglobulinemia is present in HCV-related glomerulonephritis.
The HCV is lymphotropic and hepatotropic virus that leads to various forms of immunological disease 3, 7 . Type II cryoglobulins may have IgMκ as a rheumatoid factor, which has a strong affinity for cellular fibronectin.
In mesangial cells, many cellular fibronectins are expressed; therefore, MPGN develops because cryoglobulins precipitate in the matrix 5 . Also, recent studies indicate that immunocomplexes form in situ and make the α-enolace in mesangial cells a target antigen 24 .
Treatments for HCV-related glomerulonephritis include IFN, steroids, and cryofiltration, but there is no gold standard 25 . In the present case, IFN therapy was indicated by the serotype and the viral titer. Many reports support the efficacy of IFN therapy 15, 26, 27 , which is widely accepted as a rationalized eradicative therapy for HCV-induced cryoglobulinemia 28 . symptoms in the present case, but because cryoglobulinemia had been diagnosed, is unlikely that HCV was exclusively attributed. Differentiating the other 2 causes, however, is difficult. As far as CNS symptoms are concerned, inflammatory conditions, such as angiopathy and cerebritis, were ruled out, and the symptoms were attributed to IFN therapy or cryoglobulinemia, although the mechanism remains unclear. However, in the present case, the cryoglobulinemia developed before hospitalization, and the cryoglobulinemia tended to worsen, and, the psychoneurological symptoms also developed after IFN therapy was started. Despite the discontinuation of IFN therapy and the continuing treatment for cryoglobulinemia, no improvement was seen; therefore, it was difficult to find out the etiology. A definitive cause could not be determined with autopsy because the patient had received ventilatory support, which affects the tissues, and bleeding was prominent because of disseminated intravascular coagulation at life-or-death crisis.
Conclusion
We have reported a case of HCV-related nephropathy associated with marked psychoneurological symptoms. We could not definitively determine whether the symptoms were manifestations of the HCV-related nephropathy or side effects of IFN therapy or both. However, we believe this case report provides some insight into whether IFN therapy should be administered for HCV-related glomerulonephritis associated with cryoglobulinemia.
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